The Press Office provides journalists with information on the diverse range of subjects that are relevant to the pharmaceutical industry. Our role is to ensure that any type of media is able to have access to the industry perspective and opinion.
The Association of the British Pharmaceutical Industry (ABPI) have responded to the Competition and Markets Authority (CMA) infringement decision on Pfizer and Flynn Pharma.Read more
Lisa Anson, President of AstraZeneca UK and Ireland has been elected as the next President of the Association of the British Pharmaceutical Industry. The role will be effective from end April 2017.Read more
Following today’s announcement from NHS England regarding the extension of the national HIV prevention programme with Public Health England, and funding for ten new specialised treatments the ABPI said:Read more
Dr Virginia Acha, ABPI's Executive Director of Research, Medical and Innovation has told MPs on the Exiting the European Union (EU) Committee that for the UK pharmaceutical industry a primary objective for Government in Brexit negotiations should be to secure alignment and cooperation with EU medicines regulation.Read more
Patients and representatives from across the medical research sector came together (28 November) at the inaugural Patients First Conference, hosted jointly by the Association of Medical Research Charities (AMRC) and the Association of the British Pharmaceutical Industry (ABPI), to explore how medical research can deliver better outcomes for patients.Read more
Cardiff, Monday November 28th 2016
The Association of the British Pharmaceutical Industry (ABPI) Cymru Wales annual conference held at the Life Sciences Hub, Cardiff Bay [24 Nov], highlighted the importance of collaboration between the NHS, patients and the pharmaceutical industry in Wales to improve outcomes for all.
Pharmaceutical companies are showing a ‘significant trend’ towards increased clinical trial transparency according to a new ABPI study published in the peer-review journal Current Medical Research and Opinion (CMRO).Read more
The ABPI welcomes the government’s recognition of investing in science, research and development, and its commitment to creating an industrial strategy which supports science and innovation.Read more
The ABPI welcomes the Government’s announcement to invest an extra £2billion a year in to science research and development by the end of this parliament. The ABPI also welcomes the government’s commitment to support and invest in science and technology innovation through its industrial strategy and looks forward to hearing more about how it will ensure the UK becomes the best place in the world to support the discovery, clinical development and use of innovative medicines. Read more
The Association of the British Pharmaceutical Industry (ABPI) is delighted to announce that its education team are the proud winners of the ‘Best Online Education’ for the ABPI schools website.Read more